These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 26313223

  • 1. Linking germline and somatic variation in Ewing sarcoma.
    Gomez NC, Davis IJ.
    Nat Genet; 2015 Sep; 47(9):964-5. PubMed ID: 26313223
    [Abstract] [Full Text] [Related]

  • 2. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
    Grünewald TG, Bernard V, Gilardi-Hebenstreit P, Raynal V, Surdez D, Aynaud MM, Mirabeau O, Cidre-Aranaz F, Tirode F, Zaidi S, Perot G, Jonker AH, Lucchesi C, Le Deley MC, Oberlin O, Marec-Bérard P, Véron AS, Reynaud S, Lapouble E, Boeva V, Rio Frio T, Alonso J, Bhatia S, Pierron G, Cancel-Tassin G, Cussenot O, Cox DG, Morton LM, Machiela MJ, Chanock SJ, Charnay P, Delattre O.
    Nat Genet; 2015 Sep; 47(9):1073-8. PubMed ID: 26214589
    [Abstract] [Full Text] [Related]

  • 3. Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding.
    Lee OW, Rodrigues C, Lin SH, Luo W, Jones K, Brown DW, Zhou W, Karlins E, Khan SM, Baulande S, Raynal V, Surdez D, Reynaud S, Rubio RA, Zaidi S, Grossetête S, Ballet S, Lapouble E, Laurence V, Pierron G, Gaspar N, Corradini N, Marec-Bérard P, Rothman N, Dagnall CL, Burdett L, Manning M, Wyatt K, Yeager M, Chari R, Leisenring WM, Kulozik AE, Kriebel J, Meitinger T, Strauch K, Kirchner T, Dirksen U, Mirabello L, Tucker MA, Tirode F, Armstrong GT, Bhatia S, Robison LL, Yasui Y, Romero-Pérez L, Hartmann W, Metzler M, Diver WR, Lori A, Freedman ND, Hoover RN, Morton LM, Chanock SJ, Grünewald TGP, Delattre O, Machiela MJ.
    Am J Hum Genet; 2023 Mar 02; 110(3):427-441. PubMed ID: 36787739
    [Abstract] [Full Text] [Related]

  • 4. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN, Tang N, Fleming JT, Ma Y, Guo Y, Borinstein SC, Chiang C, Wang J.
    Oncotarget; 2016 Jul 12; 7(28):43504-43517. PubMed ID: 27259270
    [Abstract] [Full Text] [Related]

  • 5. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma.
    Sankar S, Bell R, Stephens B, Zhuo R, Sharma S, Bearss DJ, Lessnick SL.
    Oncogene; 2013 Oct 17; 32(42):5089-100. PubMed ID: 23178492
    [Abstract] [Full Text] [Related]

  • 6. Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis.
    Stoll G, Surdez D, Tirode F, Laud K, Barillot E, Zinovyev A, Delattre O.
    Nucleic Acids Res; 2013 Oct 17; 41(19):8853-71. PubMed ID: 23935076
    [Abstract] [Full Text] [Related]

  • 7. Primary Hepatic Ewing Sarcoma With EWS-FLI1 RNA Transcript in a Child.
    Pochon C, Martelli H, Mussini C, Pariente D, Heymann MF, Corradini N.
    J Pediatr Hematol Oncol; 2015 Jul 17; 37(5):411-3. PubMed ID: 25411865
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
    Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB.
    Cancer; 2015 Mar 01; 121(5):697-707. PubMed ID: 25387699
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
    Ban J, Siligan C, Kreppel M, Aryee D, Kovar H.
    Adv Exp Med Biol; 2006 Mar 01; 587():41-52. PubMed ID: 17163154
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
    Rodríguez-Núñez P, Romero-Pérez L, Amaral AT, Puerto-Camacho P, Jordán C, Marcilla D, Grünewald TG, Alonso J, de Alava E, Díaz-Martín J.
    J Pathol; 2020 Apr 01; 250(4):374-386. PubMed ID: 31880317
    [Abstract] [Full Text] [Related]

  • 16. DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.
    Sheffield NC, Pierron G, Klughammer J, Datlinger P, Schönegger A, Schuster M, Hadler J, Surdez D, Guillemot D, Lapouble E, Freneaux P, Champigneulle J, Bouvier R, Walder D, Ambros IM, Hutter C, Sorz E, Amaral AT, de Álava E, Schallmoser K, Strunk D, Rinner B, Liegl-Atzwanger B, Huppertz B, Leithner A, de Pinieux G, Terrier P, Laurence V, Michon J, Ladenstein R, Holter W, Windhager R, Dirksen U, Ambros PF, Delattre O, Kovar H, Bock C, Tomazou EM.
    Nat Med; 2017 Mar 01; 23(3):386-395. PubMed ID: 28134926
    [Abstract] [Full Text] [Related]

  • 17. Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors.
    Li Y, Li X, Fan G, Fukushi J, Matsumoto Y, Iwamoto Y, Zhu Y.
    Cancer Lett; 2012 Jul 01; 320(1):14-22. PubMed ID: 22266186
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Extraskeletal Ewing's sarcoma in a 67-year-old man.
    Hanaoka N, Goto T, Kasai T, Matsuura T, Nishisho T, Enishi T, Yasui N.
    J Orthop Sci; 2011 Mar 01; 16(2):250-2. PubMed ID: 21327980
    [No Abstract] [Full Text] [Related]

  • 20. Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma.
    Johnson KM, Taslim C, Saund RS, Lessnick SL.
    PLoS One; 2017 Mar 01; 12(11):e0186275. PubMed ID: 29091716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.